The conference occurs every two years, with the next hybrid meeting taking place in New York City in November 2021.  

The summit will be addressing novel therapies for the treatment of inflammatory dermatological conditions affecting both adults and children. Under the umbrella of the event, the technological, scientific, and medical revolution of concepts in treating inflammatory diseases, such as psoriasis, vitiligo, atopic dermatitis, and many more, and the implication of targeted therapeutics will be discussed and demonstrated by world-renowned scientists and experts. 

We are excited to announce that CEO Dr. Harald Schnidar will be among the presenting experts talking about the outcome of SCARLETRED´s latest clinical study, The Mathematics of Erythema: Development of Machine Learning Models for Artificial Intelligence Assisted Measurement and Severity Scoring of Radiation-Induced Technology (Ranjan et al., 2021).  

‍

You can take a glance at the poster presentation here or on the official poster gallery of the summit.

‍

Visit the official homepage of the 4th Inflammatory Skin Disease Summit to find out more about the event.